MassDevice

Boston Scientific reports positive findings for Ekos endovascular system in pulmonary embolism

Boston Scientific (NYSE:BSX) announced positive data from a randomized clinical trial evaluating its EKOS endovascular system.
WIS TV

What is EKOS? This medical procedure saved an Irmo woman's life

IRMO, SC (WIS) - A 36-year-old Irmo woman started having shortness of breath. That developed into chest pains and dizziness. A CT scan revealed a life-threatening health situation - a blood clot.
KTBS 3

HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism

Global randomized trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. antico ...
Endovascular Today

HI-PEITHO: Boston Scientific’s Ekos System Superior to Anticoagulation Alone in Acute Intermediate-Risk PE

Boston Scientific Corporation announced that the HI-PEITHO global randomized clinical trial evaluating the use of the Ekos endova ...
kristv

A new tool in the fight against pulmonary embolism

CORPUS CHRISTI, Texas — A local procedure is now available here in Corpus Christi for high-risk patients with pulmonary embolism. Pulmonary embolism is a blockage in one of the pulmonary arteries in ...
Nasdaq

REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS™ Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of ...

Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices Each year, approximately 350,000 patients in the United ...